Sarah Baker
(she/her)
Teams and roles for Sarah Baker
Biobank Operations Manager
Bls Biohta
Publication
2024
- Burton, R. J. et al. 2024. Conventional and unconventional T cell responses contribute to the prediction of clinical outcome and causative bacterial pathogen in sepsis patients. Clinical & Experimental Immunology 216 (3), pp.293-306. (10.1093/cei/uxae019)
2023
- Cuff, S. et al. 2023. Inflammatory biomarker signatures in post-surgical drain fluid may detect anastomotic leaks within 48 hours of colorectal resection. Techniques in Coloproctology (10.1007/s10151-023-02841-y)
2022
- Menezes, A. C. et al. 2022. Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia 36 , pp.1769-1780. (10.1038/s41375-022-01577-2)
- Menezes, A. C. et al. 2022. RUNX3 overexpression inhibits normal human erythroid development. Scientific Reports 12 1243. (10.1038/s41598-022-05371-z)
2021
- Burton, R. J. et al. 2021. CytoPy: An autonomous cytometry analysis framework. PLoS Computational Biology 17 (6) e1009071. (10.1371/journal.pcbi.1009071)
- Rastogi, N. et al. 2021. Use of an anti-CD200 blocking antibody improves immune responses to AML in vitro and in vivo. British Journal of Haematology 193 (1), pp.155-159. (10.1111/bjh.17125)
2020
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34 (2), pp.427-440. (10.1038/s41375-019-0596-4)
- Raffray, L. et al. 2020. Zoledronate rescues immunosuppressed monocytes in sepsis patients. Immunology 159 (1), pp.88-95. (10.1111/imm.13132)
Articles
- Burton, R. J. et al. 2024. Conventional and unconventional T cell responses contribute to the prediction of clinical outcome and causative bacterial pathogen in sepsis patients. Clinical & Experimental Immunology 216 (3), pp.293-306. (10.1093/cei/uxae019)
- Cuff, S. et al. 2023. Inflammatory biomarker signatures in post-surgical drain fluid may detect anastomotic leaks within 48 hours of colorectal resection. Techniques in Coloproctology (10.1007/s10151-023-02841-y)
- Menezes, A. C. et al. 2022. Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia 36 , pp.1769-1780. (10.1038/s41375-022-01577-2)
- Menezes, A. C. et al. 2022. RUNX3 overexpression inhibits normal human erythroid development. Scientific Reports 12 1243. (10.1038/s41598-022-05371-z)
- Burton, R. J. et al. 2021. CytoPy: An autonomous cytometry analysis framework. PLoS Computational Biology 17 (6) e1009071. (10.1371/journal.pcbi.1009071)
- Rastogi, N. et al. 2021. Use of an anti-CD200 blocking antibody improves immune responses to AML in vitro and in vivo. British Journal of Haematology 193 (1), pp.155-159. (10.1111/bjh.17125)
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34 (2), pp.427-440. (10.1038/s41375-019-0596-4)
- Raffray, L. et al. 2020. Zoledronate rescues immunosuppressed monocytes in sepsis patients. Immunology 159 (1), pp.88-95. (10.1111/imm.13132)